...- Buccaneer Intermediate Holdco Ltd.'s (also known as Signant Health) cash flow generation is trending better than S&P Global Ratings previously projected and bookings growth is strong. - We expect improving bookings will support revenue growth and free cash flow generation over the next year. - The company obtained a new incremental term loan in November 2020, which it used to pay for two acquisitions and reduce the revolver balance, providing additional liquidity. - We are revising our rating outlook to stable from negative. At the same time, we are affirming our 'B-' issuer credit rating and 'B-' rating on Buccaneer's first-lien loan. - The stable outlook reflects our expectation that the company's revenue will grow, its EBITDA margin will expand, and the company will generate positive free cash flow, despite leverage that we expect to remain above 8x....
